| 英文别名： |
Filgotinib;Filgotinib (GLPG0634);GLPG0634;GLPG-0634 (Filgotinib);GPLG0634;GPLG-0634;N-(5-(4-((1,1-Dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide;N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide;cyclopropanecarboxylic acid {5-[ 4-(1,1-dioxo-thiomorpholin-4-ylmethyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}-amide;cyclopropanecarboxylic acid {5-[4-((1,1-dioxo-1-thimorpholin-4-yl)methyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}-amide;GLPG-0634;N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide;SYN1158;UNII-3XVL385Q0M;GLPG0634 （Filgotinib）;3XVL385Q0M;AK171369;Filgotinib [USAN:INN];GLPG 0634;N-(5-{4-[;Filgotinib(GLPG0634);G146034;N-(5-(4-((1,1-dioxido |
沪公网安备 
